Evidence map›Paper›PMID 29272356›Full record

ArticleEndocrinology2018

GRP94 Is an Essential Regulator of Pancreatic β-Cell Development, Mass, and Function in Male Mice.

Do-Sung Kim, Lili Song, Jingjing Wang, Hongju Wu, Guoqiang Gu, Yukiko Sugi, Zihai Li, Hongjun Wang

Open access · bronzeAbstract read
In one paragraph

Article in Endocrinology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. GRP94 is indispensable for definitive endoderm specification of human induced pluripotent stem cells.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. ENPL-1, theDevelopment (Cambridge, England) · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Do-Sung KimDepartment of Surgery, Medical University of South Carolina, Charleston, South Carolina.
Lili SongDepartment of Surgery, Medical University of South Carolina, Charleston, South Carolina.
Jingjing WangDepartment of Surgery, Medical University of South Carolina, Charleston, South Carolina.
Hongju WuDepartment of Medicine, Tulane University, New Orleans, Louisiana.
Guoqiang GuDepartment of Cell and Developmental Biology, Vanderbilt University Medical Center, Nashville, Tennessee.
Yukiko SugiRegenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, South Carolina.
Zihai LiMicrobiology and Immunology, Medical University of South Carolina, Charleston, South Carolina.
Hongjun WangDepartment of Surgery, Medical University of South Carolina, Charleston, South Carolina.
Medical University of South Carolina · USTulane University · USVanderbilt University Medical Center · US

Funding

Project 3: Structural Basis for grp94 Drug Development and Chaperone FunctionP01CA186866 · NCI · OHIO STATE UNIVERSITY · PI LI, ZIHAI · 2015 to 2019
$6.7M
The Mechanisms of Islet Cell Specification and DifferentiationR01DK065949 · NIDDK · VANDERBILT UNIVERSITY · PI GU, GUOQIANG · 2004 to 2017
$4.4M
Alpha1 Anti-trypsin Enhances Islet Autograft SurvivalR01DK105183 · NIDDK · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI WANG, HONGJUN · 2016 to 2020
$2.0M
Pax4-induced alpha-to-beta cell conversionR01DK107412 · NIDDK · TULANE UNIVERSITY OF LOUISIANA · PI WU, HONGJU · 2016 to 2018
$1.0M
A Novel Approach to Prevent Surgical Diabetes in Chronic Pancreatitis PatientsR21DK097544 · NIDDK · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI WANG, HONGJUN · 2014 to 2015
$411k
Islet and Mesenchymal Stem Cell Co-transplantation Prevents Onset of DiabetesR21DK099696 · NIDDK · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI WANG, HONGJUN · 2013 to 2014
$411k
Novel Strategies to Increase Insulin Independence after Islet AutotransplantationR03EB015744 · NIBIB · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI WANG, HONGJUN · 2013 to 2014
$147k
NCI NIH HHS P01 CA186866NIBIB NIH HHS R03 EB015744NIDDK NIH HHS R01 DK065949NIDDK NIH HHS R01 DK105183NIDDK NIH HHS R01 DK107412NIDDK NIH HHS R21 DK097544NIDDK NIH HHS R21 DK099696
6 · The paper itself

Abstract

Deficiencies in pancreatic β-cell mass contribute to both type 1 and type 2 diabetes. We investigated the role of the glucose-regulated protein (GRP) 94, an endoplasmic reticulum protein abundantly expressed in the pancreatic acini and islets, in β-cell development, survival, and function. We used a conditional knockout (KO) mouse in which the GRP94 gene, Hsp90b1, was specifically deleted in pancreatic and duodenal homeobox 1 (Pdx1)-expressing cells. These Hsp90b1 flox/flox;Pdx1Cre KO mice exhibited pancreatic hypoplasia at embryonic day (E) 16.5 to E18.5 and had significantly reduced β-cell mass at 4 weeks after birth. Further mechanistic studies showed that deletion of GRP94 reduced β-cell proliferation with increased cell apoptosis in both Pdx1+ endocrine progenitor cells and differentiated β cells. Although Hsp90b1 flox/flox;Pdx1Cre KO mice remained euglycemic at 8 weeks of age, they exhibited impaired glucose tolerance. In aggregate, these findings indicate that GRP94 is an essential regulator of pancreatic β-cell development, mass, and function.

Indexed as

AnimalsCell CountCell DifferentiationCell ProliferationCells, CulturedEmbryo, NonmammalianGlucose IntoleranceHEK293 CellsHumansInsulin-Secreting CellsMaleMembrane GlycoproteinsMiceMice, Inbred C57BLMice, KnockoutOrgan SizeendoplasminMembrane Glycoproteins

Identifiers

PMID29272356
PMCPMC5793778
OpenAlexW2780317778

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.